Equity · Healthcare
CI
The Cigna Group · NYSE
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CI to draw a line in its place.
The chart above plots the price of CI over the range selected — one day to the full history — drawn by TradingView from their own data.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 10, 2026
CI insider trades
CI has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 5 August 2026.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 37 compensation filings in this window. The figures above count all of them.
CI reported financials
CI reported revenue of $274.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $6.0B.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
CI earnings
Reported figures & scheduled dates · SEC EDGAR filings
CI institutional holders
1 of the 45 institutional funds we track reported a CI position for the quarter ended 30 Jun 2026 — a combined $1.2M; the latest of those filings landed 04 Aug 2026.
Source: SEC EDGAR 13F filings
Congressional trades in CI
The most recent congressional trade disclosed in CI is a purchase by Julie Johnson (house, TX), dated 23 Sep 2025.
Source: U.S. House of Representatives financial disclosures